While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy
They must ensure their products are safe and that label claims are not misleading, but the burden of proving a product is unsafe falls on the FDA, not the manufacturer
Clinical Evidence and Impact on Diabetes Multiple randomized controlled trials have documented that GLP1 receptor agonists not only enhance glycemic control but also lead to meaningful weight reduction
Compared with the class of oral diabetes medications called SGLT2 inhibitors, GLP-1 therapies usually result in greater weight loss and stronger blood sugar lowering
Key point: because formulas vary, your first question should always be: What exactly is in the injection, and why is it appropriate for me? Do Lipotropic Injections Work for Weight Loss